Trudeau Govt To Make COVID Test Mandatory For Canada-Bound Flyers

2 min read | December 31, 2020 04:08 AM EST | By Kunal Sawhney

Summary

  • The federal government plans to make it a requirement that air passengers pass a COVID-19 PCR test three days before they arrive in Canada.
  • The Trudeau government cabinet has arrived at the decision to enact this rule as quickly as possible.
  • Parts of Canada are currently in the grips of a second wave of the coronavirus infections, with Ontario hitting a new record of 2,923 on Wednesday.

The Trudeau government plans to stipulate a COVID-19 PCR test for travelers flying to Canada three days before their arrival, and allow them into the country only if they test negative. Minister of Intergovernmental Affairs Dominic LeBlanc said on Wednesday, December 30, that the Cabinet has arrived at the decision to enact this rule as quickly as possible.

Parts of Canada are currently in the grips of a second wave of the coronavirus infections, with Ontario hitting a new record of 2,923 on Wednesday.

©Kalkine Group Image

 

The latest announcement comes in the wake of Ontario Finance Minister Rod Phillips facing heat for travelling abroad for vacation in the midst of a province-wide lockdown. The federal government has been receiving flak recently for over its “lax” travel restrictions and quarantine protocols.

 

Canada’s Fight Against COVID-19

 

 

  • Prime Minister Justin Trudeau said that some 249,000 doses of the Pfizer- BioNTech shot was scheduled to reach Canada in December, while a consignment of another three million doses was set to come by January next year.
  • Canada banned passenger flights coming from Britain when the news of rising cases of the mutant coronavirus strain broke earlier in December.
  • The AstraZeneca-Oxford vaccine, which got a thumbs-up on Wednesday from the UK government for public use, is reportedly under evaluation along with the Johnson & Johnson vaccine in Canada.
  • The federal government has reportedly reserved a total of over 400 million COVID-19 vaccine doses from different pharmaceutical companies.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.